Scholarlink

<p>The interactions of pediatricians and their professional organizations with commercial providers of dietary foods, criticized by the WHO for many years and subject to ongoing controversy, were the subject of an expert discussion at the 51st DACH Symposium for Pediatric Preventive and Nutritional Medicine of the Austrian Society of Pediatrics and Adolescent Medicine in January 2026. All participants expressed support for the proactive promotion, protection and encouragement of breastfeeding as the best form of infant nutrition, particularly by pediatricians. From the perspective of pediatrics, the regulations governing the appropriate marketing of infant foods require further adjustment, especially regarding limiting the advertising of follow-on formulas for infants and restricting digital and influencer-based marketing. Interactions between pediatricians and their organizations with commercial actors carry risks of potential conflicts of interest and therefore require clear legal and professional regulations as well as adherence to transparent codes of conduct. Financial support of congresses and other educational and scientific activities of medical scientific societies and professional organizations by commercial actors is only considered an acceptable option if appropriate social, legal, scientific and ethical standards are upheld. These standards include, in particular, the exclusion of any influence on programs and content, as well as ensuring transparency regarding financial support. Risks exist across sectors, so that corresponding regulations must be applied uniformly to all companies. Pediatrics calls on companies to cease their sponsorship of purely commercially oriented training formats that are offered without the leadership and supervision of a&#xa0;reputable pediatric organization and that directly oppose the interests of pediatrics and often also of child health and of the general public. Public funding of pediatric continuing education should be sustainably strengthened to reduce the share of commercial sponsors in financing professional training.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Sponsoring durch Anbieter diätetischer Lebensmittel – legitim oder unzulässig?

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月19日

查看全文
  • Berthold Koletzko,
  • Burkhard Rodeck,
  • Marin W. Weber,
  • Nadja Haiden,
  • Norbert Pahne,
  • Anna-Maria Schneider,
  • Daniel Weghuber

摘要

The interactions of pediatricians and their professional organizations with commercial providers of dietary foods, criticized by the WHO for many years and subject to ongoing controversy, were the subject of an expert discussion at the 51st DACH Symposium for Pediatric Preventive and Nutritional Medicine of the Austrian Society of Pediatrics and Adolescent Medicine in January 2026. All participants expressed support for the proactive promotion, protection and encouragement of breastfeeding as the best form of infant nutrition, particularly by pediatricians. From the perspective of pediatrics, the regulations governing the appropriate marketing of infant foods require further adjustment, especially regarding limiting the advertising of follow-on formulas for infants and restricting digital and influencer-based marketing. Interactions between pediatricians and their organizations with commercial actors carry risks of potential conflicts of interest and therefore require clear legal and professional regulations as well as adherence to transparent codes of conduct. Financial support of congresses and other educational and scientific activities of medical scientific societies and professional organizations by commercial actors is only considered an acceptable option if appropriate social, legal, scientific and ethical standards are upheld. These standards include, in particular, the exclusion of any influence on programs and content, as well as ensuring transparency regarding financial support. Risks exist across sectors, so that corresponding regulations must be applied uniformly to all companies. Pediatrics calls on companies to cease their sponsorship of purely commercially oriented training formats that are offered without the leadership and supervision of a reputable pediatric organization and that directly oppose the interests of pediatrics and often also of child health and of the general public. Public funding of pediatric continuing education should be sustainably strengthened to reduce the share of commercial sponsors in financing professional training.